Watch LIVE on Tuesday May 20th, 2025 @ 5:30 PM PST

Program Abstract:

Epstein-Barr Virus (EBV) has had an unusual evolution in acute and chronic illness care and management. Partially this is due to the relatively short history of modern virology evolving concurrently with our understanding of EBV. EBV went from a known cause of “Mono” with very rudimentary testing, to the “cause of everything”, to a seeming enigma of modern virological import. In this discussion we will look at the history of the virus, evolution and importance of various tests, an extensive literature review, clinical presentations and modern understandings. The specific evolution of EBV testing will be informed by Dr. Anderson’s collaboration with the virologist who was the original inventor of EBV and other HHV testing platforms. The relationship of EBV to cancer and autoimmunity will also be discussed. The critical clinical determinants of assessing the “sick user” versus the “well user” effect will also be incorporated, leading to a summary of where we are now and how to manage this nuanced clinical entity.

Learning Objectives:

• Define the biology of EBV as an HHV virus
• Describe the known role of EBV and HHV in acute and chronic infections
• Define the EBV associated non-infectious diseases
• Discuss testing methodologies and platforms bases, uses, and misuses.
• Discuss cross-reactivity in testing platforms
• Describe appropriate clinical interventions and monitoring for EBV infection

CME Effective Date: Live Event May 20th, 2025

CME Expiration Date: Live Event June 20, 2025

Educational Credits: 2.0 AMA/PRA Category 1 CME Credit™ | 1.0 Pharmacology

Target Audience:
This program is intended for: Physicians (MD, ND, Other), Nurses, Nurse Practitioners, and Other Healthcare professionals.

Conflict of Interest Disclosure Policy 

Identify, Mitigate, and Disclose Relevant Financial Relationships 

Many healthcare professionals have financial relationships with ineligible companies.  These relationships must not be allowed to influence accredited continuing education.  The Foundation for Care Management (FCM) as the accredited provider is responsible for identifying relevant financial relationships between individuals in control of educational content and ineligible companies and managing these to ensure they do not introduce commercial bias into the education. Financial relationships are defined as relevant if the educational content is related to the business lines or products of the ineligible company.  As an accredited provider FCM collects information from planners, faculty and others in control of educational content and conducts an extensive review process.  Financial relationships are identified, reviewed and mitigated.  In some cases. speakers and committee members may be excluded.  All relevant financial relationships are disclosed to the learner below as required by the ACCME

Disclosures  The Information shown below may change upon receipt of signed disclosures & updates for reviewers

Planner/Planner:
Dr. Paul Anderson discloses the following: NFH – Vitazan; Science Advisory Board Member, MD Lifespan; Science Advisory Board Member, Priority One; Formulation Advisor.

Reviewers:

Dr. Kasra Pournadeali and Kenneth Meyer discloses no financial relationships with any ineligible companies.

No individual(s) at the Foundation for Care Management (FCM) who had control over the planning or content of this activity has relevant financial relationships with ineligible companies.

To the degree possible all identifying “commercial” detail has been left out of the slides.

Any proprietary products mentioned in the audio Q&A are only due to direct clarifying questions by the attendees, and no product, lab or supplier has any financial connection to the presenter.

Accreditation Statement: